Consumer products giant Clorox (NYSE:CLX) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 8% year on year to $1.67 billion. Its non-GAAP profit of $1.45 per share was 6.9% below analysts’ consensus estimates.
Is now the time to buy CLX? Find out in our full research report (it’s free).
Clorox (CLX) Q1 CY2025 Highlights:
- Revenue: $1.67 billion vs analyst estimates of $1.72 billion (8% year-on-year decline, 3.3% miss)
- Adjusted EPS: $1.45 vs analyst expectations of $1.56 (6.9% miss)
- Adjusted EBITDA: $321 million vs analyst estimates of $326.7 million (19.2% margin, 1.7% miss)
- Management reiterated its full-year Adjusted EPS guidance of $7.15 at the midpoint
- Operating Margin: 14.4%, up from 12.5% in the same quarter last year
- Free Cash Flow Margin: 14%, up from 7% in the same quarter last year
- Organic Revenue fell 2% year on year (2% in the same quarter last year)
- Market Capitalization: $16.8 billion
StockStory’s Take
Clorox’s Q1 results reflected ongoing challenges in consumer demand and heightened competition across core product categories. CEO Linda Rendle explained that while the company had anticipated a tougher consumer environment for much of the quarter, a notable shift occurred in the latter half as U.S. consumer sentiment weakened and shoppers reprioritized spending—resulting in temporary category softness and sales below expectations. Despite these pressures, management highlighted that market share held steady, and Clorox achieved its tenth consecutive quarter of gross margin expansion, which supported continued investment in brand and product innovation.
Looking ahead, management expects external pressures—including tariffs, ongoing retailer inventory adjustments, and macroeconomic uncertainty—to persist. CFO Luc Bellet noted that while the company’s exposure to tariffs is limited, mitigation efforts such as targeted pricing and cost savings are underway. Clorox continues to prioritize margin management and operational efficiency, reiterating its guidance for full-year adjusted earnings per share, and emphasizing that its portfolio of essential brands positions it to navigate ongoing volatility. Rendle remarked, “We are confident in our ability to manage through uncertainty and deliver value to consumers and shareholders.”
Key Insights from Management’s Remarks
Clorox’s leadership addressed the main factors influencing Q1 performance, with particular emphasis on shifting consumer behaviors and operational adjustments. Management discussed both the impact of external events and the company’s responses.
- Consumer Spending Shifts: The company cited changing consumer priorities and macroeconomic concerns as drivers of reduced demand in household essentials, with shoppers reallocating budgets toward larger purchases such as automobiles and electronics.
- Retailer Inventory Adjustments: Retailers reduced inventory levels in certain categories late in the quarter, particularly in the household segment, contributing to lower sales. Management characterized these moves as tactical, not structural, and expects continued volatility in Q2.
- Competitive Promotional Activity: Increased discounting from competitors, especially in the Glad trash bags category, led to elevated promotional spending. Clorox responded selectively, aiming to maintain value perception while resisting unsustainable pricing strategies.
- Innovation and Premiumization: The company reported ongoing success with premium product launches—such as Scentiva and ToiletWand in cleaning and premium cat litter offerings—underscoring consumer willingness to pay for innovation that delivers superior value.
- Category Share and Channel Mix: Despite volatility, Clorox maintained overall market share. The company noted resilience in cleaning and grilling, while seeing channel shifts toward club and mass retail, aligning with its established distribution strengths.
Drivers of Future Performance
Clorox expects the coming quarters to be shaped by continued consumer caution, retailer inventory management, and the company’s ability to offset external cost pressures through efficiency gains.
- Tariff Mitigation Efforts: Management identified new tariffs as a key headwind; targeted price increases, sourcing changes, and cost-saving initiatives are expected to partially offset the impact, with approximately $100 million in annual exposure.
- Retailer and Consumer Behavior: The pace of category recovery depends on consumer confidence and retailers’ inventory strategies. Management is closely monitoring for signs of channel shifting, pack size changes, and potential trade-down to private label alternatives.
- Efficiency and Productivity Initiatives: Ongoing investments in technology, including the ERP transition, and holistic margin management are intended to maintain or expand margins despite softer top-line trends.
Top Analyst Questions
- Dara Mohsenian (Morgan Stanley): Asked about the persistence of category weakness and how it compares to previous cycles; CEO Linda Rendle explained volatility is driven by consumer wallet shifts and macro uncertainty, with no significant behavioral change in product usage.
- Filippo Falorni (Citi): Inquired about the gross margin impact of tariffs and mitigation plans; CFO Luc Bellet quantified $100 million annual exposure and described sourcing, reformulation, and selective price increases as key responses.
- Anna Lizzul (Bank of America): Questioned promotional activity by category, particularly in Glad; Rendle confirmed elevated competitive discounting and described efforts to maintain promotional discipline while supporting innovation.
- Bonnie Herzog (Goldman Sachs): Sought an update on the ERP transition and its effect on inventory and margins; management outlined that retailer inventory build will temporarily boost Q2 sales, with reversal expected in the following quarters.
- Chris Carey (Wells Fargo): Pressed on whether productivity initiatives can offset tariff and ERP-related headwinds; Rendle emphasized Clorox’s ongoing cost management capabilities and anticipated further efficiency gains post-ERP implementation.
Catalysts in Upcoming Quarters
Over the next few quarters, the StockStory team will track (1) Clorox’s ability to manage tariff-related cost pressures through pricing and operational changes, (2) normalization of retailer inventory levels and its impact on sales trends, and (3) consumer adoption of new premium product innovations in a value-focused environment. Continued execution on cost savings and ERP integration will also be closely watched as indicators of future margin performance.
Clorox currently trades at a forward P/E ratio of 18.8×. Should you double down or take your chips? Find out in our free research report.
Stocks That Trumped Tariffs in 2018
Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.
While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.